September 11, 2007 – Improving how healthcare providers follow proven protocols could reduce the risks of subsequent ...

More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.
September 11, 2007 - The Certification Commission for Healthcare Information Technology (CCHIT) and the MITRE Corp ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.
September 11, 2007 - Terumo Interventional Systems announces the launch of its breakthrough Runthrough NS Coronary ...
CT scanners have evolved over the years and are showing to have applications in the emergent and non-emergent evaluation of underlying cardiovascular issues. The general acceptance for cardiovascular evaluation by CT is limited due to ongoing studies.
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.

When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...

According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.